The U.S. prison population plummeted during the early months of the COVID-19 pandemic but the percentage of incarcerated Black people rose, according to a new analysis of prison data published April 19 in the journal Nature.
The higher percentage of...
Omicron subvariants of SARS-CoV-2 — the virus behind COVID-19 — have shown an uncanny knack for evading antibodies produced either by vaccines or exposure to earlier versions of the virus, leading to many breakthrough infections. However, in order to...
Two Yale labs will lead projects, in collaboration with other leading research universities, tasked with developing new approaches to understand and combat pathogens. The ambitious projects will be funded by the Howard Hughes Medical Institute’s (HHMI)...
Neuroimaging technology has been shown to hold great promise in helping clinicians link specific symptoms of mental health disorders to abnormal patterns of brain activity. But a new Yale-led study shows there are still kinks to be ironed out before...
The investigational drug lecanemab slowed clinical decline in participants with early-stage Alzheimer’s disease by 27% after 18 months of treatment compared with participants who received a placebo, a phase 3 clinical trial has reported.
The results of...
The long-term effects of infection on the immune system have long intrigued John Tsang, a Yale immunobiologist. After the body has faced down a pathogen, does the immune system return to the previous baseline? Or does a single infection change it in ways...
As the COVID-19 pandemic showed, potentially dangerous new viruses can begin to spread in the population well before the global public health surveillance system can detect them.
However, Yale researchers have found that testing for the presence of a...
Since he was a kid Hal Blumenfeld has wondered about the nature of human consciousness.
“It’s what makes us human and makes life worthwhile,” said Blumenfeld, now the Mark Loughridge and Michele Williams Professor of Neurology at Yale. “And it’s still a...
The formation of amyloid plaques in the brain is a hallmark of Alzheimer’s disease. But drugs designed to reduce accumulations of these plaques have so far yielded, at best, mixed results in clinical trials.
Yale researchers have found, however, that...
A common feature of autism spectrum disorder, ASD, is reduced eye contact with others in natural conditions. Although eye contact is a critically important part of everyday interactions, scientists have been limited in studying the neurological basis of...